Potential Monoclonal Antibody Treatment for Lassa Fever Found
Mirage News, Aug. 25, 2023
New UTMB research points to an effective treatment for Lassa fever, a dangerous, often fatal disease common to much of West Africa but considered a major threat to global health. "This study represents yet another proof that broad protective treatments, here against the highly complex and variable hemorrhagic fever Lassa virus, can be developed with cutting-edge research within secure high-containment laboratory environments," said UTMB’s Dr. Gary Kobinger.